9018 Federal Register / Vol. 76, No. 32 / Wednesday, February 16, 2011 / Notices 

ESTIMATED ANNUALIZED BURDEN TABLE—Continued 

Type of respondent Data collection name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hrs.) 

Total burden 

hours 

Trainer Exit Survey Satisfaction 

Interview—Post only pilot study.

10 1 30/60 5 

Trainer Feedback Forms (up to 10 

forms)—Full Evaluation.

30 10 5/60 25 

Total Project Burden Hours .......... ........................................................ ........................ ........................ ........................ 1,464 

Seleda Perryman, 

Office of the Secretary, Paperwork Reduction 

Act Clearance Officer. 

[FR Doc. 2011–3442 Filed 2–15–11; 8:45 am] 

BILLING CODE 4150–33–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control 

Special Emphasis Panel (SEP): 

Annual Estimates of Influenza Vaccine 

Effectiveness for Preventing LaboratoryConfirmed Influenza in the United 

States, Funding Opportunity 

Announcement (FOA), IP11–003, Initial 

Review 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date: 8 a.m.–5 p.m., April 

7, 2011 (Closed). 

Place: Sheraton Gateway Hotel 

Atlanta Airport, 1900 Sullivan Road, 

Atlanta, Georgia 30337, Telephone: 

(770) 997–1100. 

Status: The meeting will be closed to 

the public in accordance with 

provisions set forth in Section 

552b(c)(4) and (6), Title 5 U.S.C., and 

the Determination of the Director, 

Management Analysis and Services 

Office, CDC, pursuant to Public Law 92– 

463. 

Matters To Be Discussed: The meeting 

will include the initial review, 

discussion, and evaluation of 

applications received in response to 

‘‘Annual Estimates of Influenza Vaccine 

Effectiveness for Preventing LaboratoryConfirmed Influenza in the United 

States, FOA IP11–003.’’ 

Contact Person for More Information: 

Gregory Anderson, M.S., M.P.H., 

Scientific Review Officer, CDC, 1600 

Clifton Road, NE., Mailstop E60, 

Atlanta, Georgia 30333, Telephone: 

(404) 498–2293. The Director, 

Management Analysis and Services 

Office, has been delegated the authority 

to sign Federal Register notices 

pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: February 4, 2011. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2011–3525 Filed 2–15–11; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Emerging 

Infections Sentinel Network (EISN) 

Research, Funding Opportunity 

Announcement (FOA), CK11–002, 

Initial Review 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC), 

announces the aforementioned meeting: 

Times and Dates: 12 p.m.–2 p.m., 

March 29, 2011 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to 

the public in accordance with 

provisions set forth in Section 

552b(c)(4) and (6), Title 5 U.S.C., and 

the Determination of the Director, 

Management Analysis and Services 

Office, CDC, pursuant to Public Law 92– 

463. 

Matters To Be Discussed: The meeting 

will include the initial review, 

discussion, and evaluation of 

applications received in response to 

‘‘Emerging Infections Sentinel Network 

(EISN) Research, FOA CK11–002, initial 

review.’’ 

Contact Person for More Information: 

Gregory Anderson, MS, MPH, Scientific 

Review Officer, CDC, 1600 Clifton Road, 

NE., Mailstop E60, Atlanta, Georgia 

30333, Telephone: (404) 498–2293. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: February 4, 2011. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2011–3529 Filed 2–15–11; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

National Center for Health Statistics 

(NCHS), Classifications and Public 

Health Data Standards Staff, 

Announces the Following Meeting 

Name: ICD–9–CM Coordination and 

Maintenance Committee meeting. 

Times and Dates: 9 a.m.–5:30 p.m., 

March 9, 2011. 9 a.m.–5:30 p.m., March 

10, 2011. 

Place: Centers for Medicare and 

Medicaid Services (CMS) Auditorium, 

7500 Security Boulevard, Baltimore, 

Maryland 21244. 

Status: Open to the public, limited 

only by the space available. The meeting 

room accommodates approximately 240 

people. 

Security Considerations: Due to 

increased security requirements CMS 

has instituted stringent procedures for 

entrance into the building by nongovernment employees. Attendees will 

need to present valid government-issued 

picture identification, and sign-in at the 

mstockstill on DSKH9S0YB1PROD with NOTICES